Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure
Circulation · 17.09.2024 · 150 (12) · 938-951
DOI: 10.1161/circulationaha.123.067519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 17.09.2024. Verfasst von Yunqi Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Institute of Vascular Medicine (Y.J., X.N., Y.Z., Y.T., Z.L.), Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Heart failure (HF), which is the terminal stage of many cardiovascular diseases, is associated with low survival rates and a severe financial burden. The mechanisms, especially the molecular mechanism combined with new theories, underlying the pathogenesis of HF remain elusive. We demonstrate that phosphorylation-regulated dynamic liquid–liquid phase separation of HIP-55 (hematopoietic progenitor kinase 1–interacting protein of 55 kDa) protects against HF. METHODS: Fluorescence recovery after photobleaching assay, differential interference contrast analysis, pull-down assay, immunofluorescence, and immunohistochemical analysis were used to investigate the liquid–liquid phase separation capacity of HIP-55 and its dynamic regulation in vivo and in vitro. Mice with genetic deletion of HIP-55 and mice with cardiac-specific overexpression of HIP-55 were used to examine the role of HIP-55 on β-adrenergic receptor hyperactivation-induced HF. Mutation analysis and mice with specific phospho-resistant site mutagenesis were used to identify the role of phosphorylation-regulated dynamic liquid–liquid phase separation of HIP-55 in HF. RESULTS: Genetic deletion of HIP-55 aggravated HF, whereas cardiac-specific overexpression of HIP-55 significantly alleviated HF in vivo. HIP-55 possesses a strong capacity for phase separation. Phase separation of HIP-55 is dynamically regulated by AKT-mediated phosphorylation at S269 and T291 sites, failure of which leads to impairment of HIP-55 dynamic phase separation by formation of abnormal aggregation. Prolonged sympathetic hyperactivation stress induced decreased phosphorylation of HIP-55 S269 and T291, dysregulated phase separation, and subsequent aggregate formation of HIP55. Moreover, we demonstrated the important role of dynamic phase separation of HIP-55 in inhibiting hyperactivation of the β-adrenergic receptor–mediated P38/MAPK (mitogen-activated protein kinase) signaling pathway. A phosphorylation-deficient HIP-55 mutation, which undergoes massive phase separation and forms insoluble aggregates, loses the protective activity against HF. CONCLUSIONS: Our work reveals that the phosphorylation-regulated dynamic phase separation of HIP-55 protects against sympathetic/adrenergic system–mediated heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Institute of Vascular Medicine (Y.J., X.N., Y.Z., Y.T., Z.L.), Peking University Third Hospital, Beijing, China.
- Beijing Key Laboratory of Cardiovascular Receptors Research, State Key Laboratory of Vascular Homeostasis and Remodeling, and NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking Univer…
- Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China (Y.J., X.N., Y.Z., Y.T., Z.L.).
- Interdisciplinary Research Center on Biology and Chemistry and State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China (J.G., J.H., C.L.).
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China (D.L.).
- Department of Pharmacy (Z.L.), Peking University Third Hospital, Beijing, China.
ORCID-Profile: Yunqi Jiang, Jinge Gu, Jiaojiao Hu, Zijian Li
Zitieren
APA
Jiang, Y., Gu, J., Niu, X., Hu, J., Zhang, Y., Li, D., Tang, Y., Liu, C., & Li, Z. (2024). Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure. Circulation, 150(12), 938-951. https://doi.org/10.1161/circulationaha.123.067519
Vancouver
Jiang Y, Gu J, Niu X, Hu J, Zhang Y, Li D, et al. Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure. Circulation. 2024;150(12):938-951. doi:10.1161/circulationaha.123.067519
BibTeX
@article{Jiang2024,
author = {Jiang, Yunqi and Gu, Jinge and Niu, Xiaodou and Hu, Jiaojiao and Zhang, Yongzhen and Li, Dan and Tang, Yida and Liu, Cong and Li, Zijian},
title = {Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure},
journal = {Circulation},
year = {2024},
volume = {150},
number = {12},
pages = {938--951},
doi = {10.1161/circulationaha.123.067519}
}
EUVIMED